stella
beta
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors — Stella
Recruiting
Back to Clear Cell Renal Cell Carcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
City of Hope Comprehensive Cancer Center, Duarte, California
University of California, San Francisco, San Francisco, California
University of Chicago Comprehensive Cancer Center, Chicago, Illinois
View full record on ClinicalTrials.gov